Find a Commonwealth Resource
Octreotide acetate
HealthData.Gov
Updated Apr 29, 2026
About this dataset
Octreotide Acetate is a generic prescription injectable medication, available in strengths of 200 mcg/mL and 1 mg/mL, used for intravenous or subcutaneous administration. It acts as a somatostatin analog to help manage certain hormonal conditions. Manufactured by Hikma Pharmaceuticals USA Inc. under ANDA076330. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Octreotide acetate
Access the FDA dataset for Octreotide acetate — ANDA 210317 submitted by Mylan Institutional LLC
Modified Apr 29, 2026